Jamie Nicole Justice

EBioMedicine · 2019

⊕ Open access · CC-BY

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

▲ 1,271

Physiology · 2016

⊕ Preprint · OA

Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty

▲ 273

The Journals of Gerontology Series A · 2016

⊕ Open access · CC-BY

Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience

▲ 52

The Journals of Gerontology Series A · 2019

⊕ Preprint · OA

Testing the Geroscience Hypothesis: Early Days

▲ 42

The Journals of Gerontology Series A · 2021

⊕ Preprint · OA

Eight-Year Changes in Multimorbidity and Frailty in Adults With Type 2 Diabetes Mellitus: Associations With Cognitive and Physical Function and Mortality

▲ 39

Diabetes Care · 2022

⊕ Open access · OA

An Examination of Whether Diabetes Control and Treatments Are Associated With Change in Frailty Index Across 8 Years: An Ancillary Exploratory Study From the Action for Health in Diabetes (Look AHEAD) Trial

▲ 20

The Journals of Gerontology Series A · 2024

⊕ Preprint · OA

Bringing Geroscience into the Mainstream: From Education to Clinical Practice, What Will It Take?

▲ 5

Research Square · 2025

⊕ Preprint · CC-BY

Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus

▲ 4

2022

⊕ Open access · CC-BY

An examination of whether diabetes control and treatments are associated with change in frailty index across 8 Years. An ancillary exploratory study from the Action for Health in Diabetes (Look AHEAD) Trial

▲ 2

The Journals of Gerontology Series A · 2025

⊕ Open access · CC-BY

Foundations and Strategic Vision of the Canadian Translational Geroscience Network

▲ 1

CHEST Journal · 2018

⊕ Open access · OA

TARGETING PRO-INFLAMMATORY CELLS IN IDIOPATHIC PULMONARY FIBROSIS: AN OPEN-LABEL PILOT STUDY OF DASATINIB AND QUERCETIN

▲ 1

2022

⊕ Open access · CC-BY

An examination of whether diabetes control and treatments are associated with change in frailty index across 8 Years. An ancillary exploratory study from the Action for Health in Diabetes (Look AHEAD) Trial

▲ 0

Innovation in Aging · 2021

⊕ Open access · CC-BY

Operationalizing Healthspan as an Outcome for Clinical Trials in Geroscience

▲ 0

Innovation in Aging · 2019

⊕ Open access · CC-BY

BIOMARKER STRATEGIES FOR GEROSCIENCE-GUIDED CLINICAL TRIALS

▲ 0

2024

⊕ Open access · OA

Nutrition Interventions as Geroprotectors: Design and Interpretation of Early-Stage Clinical Trial of Strawberries

▲ 0